Cancer Genetics
Rutherford, US · Delaware corporation
Biotech
Founders & leadership
RS
Raju S.K. ChagantiFounder
PL
Panna L. SharmaExecutive
ES
Edward SitarExecutive
Board
JP
John PappajohnBoard director
HM
Howard McLeodBoard director
FG
Franklyn G. PrendergastBoard director
MJ
Michael J. WelshBoard director
GH
Geoffrey HarrisBoard director
EC
Edmund CannonBoard director
Reported raises · per SEC filings
Form D private placements$26.5M disclosed across 4 rounds · 2016–2021
▶$10MraisedFeb 2021 · 6 investors · BiotechnologyRule 506(b)
▶$10MraisedFeb 2021 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John A. RobertsExecutive Officer
- Howard McLeodDirector
- Geoffrey HarrisDirector
- Franklyn G. PrendergastDirector
- Edmund CannonDirector
- Offering amount
- $10M
- Amount sold
- $10M
- Sales commissions
- $775K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6MraisedMar 2017 · 3 investors · BiotechnologyRule 506(b)
▶$6MraisedMar 2017 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Franklyn G. PrendergastDirector
- Howard McLeodDirector
- Geoffrey HarrisDirector
- Michael J. WelshDirector
- John A. RobertsExecutive Officer
- Edmund CannonDirector
- Panna L. SharmaExecutive Officer, Director
- Raju S.K. ChagantiDirector
- John PappajohnDirector
- Offering amount
- $6M
- Amount sold
- $6M
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.5MraisedDec 2016 · 16 investors · BiotechnologyRule 506(b)
▶$5.5MraisedDec 2016 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael J. WelshDirector
- Raju S.K. ChagantiExecutive Officer, Director
- Geoffrey HarrisDirector
- Howard McLeodDirector
- John PappajohnDirector
- Franklyn G. PrendergastDirector
- John A. RobertsExecutive Officer
- Edward SitarExecutive Officer
- Edmund CannonDirector
- Panna L. SharmaExecutive Officer, Director
- Offering amount
- $5.5M
- Amount sold
- $5.5M
- Sales commissions
- $385K
- Placement agents
- H.C. WainWright & Co., LLC
- First sale
- Sep 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5MraisedMay 2016 · 41 investors · BiotechnologyRule 506(b)
▶$5MraisedMay 2016 · 41 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Raju S.K. ChagantiExecutive Officer, Director
- Howard McLeodDirector
- Franklyn G. PrendergastDirector
- Panna L. SharmaExecutive Officer, Director
- Edward SitarExecutive Officer
- John PappajohnDirector
- Michael J. WelshDirector
- Geoffrey HarrisDirector
- Edmund CannonDirector
- Offering amount
- $5M
- Amount sold
- $5M
- Sales commissions
- $350K
- Placement agents
- H.C. WainWright & Co., LLC
- First sale
- May 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Cancer Genetics?
- Cancer Genetics was founded by Raju S.K. Chaganti.
- How much funding has Cancer Genetics raised?
- Cancer Genetics has disclosed $26.5M raised across 4 rounds.
- Where is Cancer Genetics headquartered?
- Cancer Genetics is headquartered in Rutherford, US.